Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
Open-market buys, last 90 days
$9,919,161,281
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Portman David J. +$9.9B 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2023-03-24 CHURCH KEVIN Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −6,410 0
2023-01-27 Litton Mark James Chief Executive Officer Grant or award · Stock Option (Right to Buy) +425,000 425,000
2023-01-19 Worthington Mark General Counsel Grant or award · Stock Option (Right to Buy) +150,000 150,000
2023-01-19 MOEBIUS HANS Chief Medical Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2023-01-19 MILESON GLENNA Chief Financial Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2023-01-19 Lenington Rachel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2023-01-19 CHURCH KEVIN Executive VP, Research Grant or award · Stock Option (Right to Buy) +150,000 150,000
2023-01-05 Gengos Andrew Sale −1,208 $2.91 $4K 83,804
2023-01-05 CHURCH KEVIN Chief Scientific Officer Sale −2,412 $2.91 $7K 80,256
2023-01-04 Gengos Andrew Grant or award +5,000 85,012
2023-01-04 CHURCH KEVIN Chief Scientific Officer Grant or award +10,000 82,668
2022-12-28 MILESON GLENNA Chief Financial Officer Purchase +50,000 $2.85 $142K 159,930
2022-12-02 Romano Kelly A Director Purchase +30,000 $3.29 $99K 38,315
2022-11-18 Litton Mark James Chief Executive Officer Grant or award +662 $2.74 $2K 129,217
2022-11-18 CHURCH KEVIN Executive VP, Research Grant or award +657 $2.74 $2K 62,052
2022-11-18 MILESON GLENNA Chief Financial Officer Grant or award +763 $2.74 $2K 109,930
2022-11-15 MOEBIUS HANS Chief Medical Officer Purchase +5,000 $3.29 $16K 65,836
2022-10-28 CHURCH KEVIN Executive VP, Research Exercise or conversion +3,700 $1.35 $5K 61,395
2022-10-28 CHURCH KEVIN Executive VP, Research Exercise or conversion · Stock Option (Right to Buy) −3,700 6,410
2022-10-13 MOEBIUS HANS Chief Medical Officer Exercise or conversion +7,881 $1.35 $11K 60,836

Page 12 of 18 · 349 trades